FOLH1 and posterior cortical atrophy: Last but not least, prostate-specific membrane antigen (PSMA), a type II transmembrane glycoprotein, was fairly lowly expressed in normal prostate tissues, but showed a massive expression in PCa tissues, offering another therapeutic target for PCa (114).